Covered recipient · General Payments record
ALLEN JAMES BALLEW
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,698.10
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $171.84 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $36.59 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.36 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.89 | 1 |
| PFIZER INC. | $15.56 | 1 |
| ABBVIE INC. | $15.49 | 1 |
| Amgen Inc. | $15.29 | 1 |
| Lilly USA, LLC | $13.82 | 1 |
| Esperion Therapeutics, Inc. | $13.37 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.34 | 1 |
| Kerecis Limited | $11.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.49 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103272469 | CMS |
| Amgen Inc. | $15.29 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196934 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.36 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118114133 | CMS |
| Esperion Therapeutics, Inc. | $13.37 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129427120 | CMS |
| Kerecis Limited | $11.13 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120091189 | CMS |
| Lilly USA, LLC | $13.82 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136027242 | CMS |
| Novartis Pharmaceuticals Corporation | $16.89 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086635069 | CMS |
| Novo Nordisk Inc | $16.37 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097838001 | CMS |
| Novo Nordisk Inc | $20.22 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097244999 | CMS |
| PFIZER INC. | $15.56 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131461327 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.34 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151038044 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.